Irlanti - englanti - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - gentamicin - solution for injection/infusion - 10 milligram(s)/millilitre - other aminoglycosides; gentamicin

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - gentamicin - solution for injection/infusion - 40 milligram(s)/millilitre - other aminoglycosides; gentamicin

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - dobutamine hydrochloride 14.01 mg/ml equivalent to dobutamine 12.5 mg/ml - concentrate for injection - 12.5 mg/ml - active: dobutamine hydrochloride 14.01 mg/ml equivalent to dobutamine 12.5 mg/ml excipient: hydrochloric acid nitrogen sodium hydroxide sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin a. acute heart failure 1. acute myocardial infarction 2. cardiogenic shock 3. following cardiac surgery 4. medicine-induced depression of cardiac contractility such as that which occurs in excessive ?- adrenergic receptor blockade. b. chronic heart failure 1. acute decompensation of chronic congestive heart failure 2. temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with convention

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - amikacin sulfate 325 mg/ml equivalent to 250 mg/ml amikacin - solution for injection - 500 mg/2ml - active: amikacin sulfate 325 mg/ml equivalent to 250 mg/ml amikacin excipient: sodium citrate dihydrate sodium hydroxide sodium metabisulfite sulfuric acid water for injection

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - teicoplanin 100mg;   - powder for injection with diluent - 100 mg - active: teicoplanin 100mg   excipient: sodium chloride sodium hydroxide water for injection

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - teicoplanin 200mg;   - powder for injection with diluent - 200 mg - active: teicoplanin 200mg   excipient: sodium chloride sodium hydroxide water for injection

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - teicoplanin 400mg - powder for injection with diluent - 400 mg - active: teicoplanin 400mg excipient: sodium chloride sodium hydroxide water for injection

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - dobutamine hydrochloride - solution for infusion - 5mg/1ml

Australia - englanti - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - teicoplanin, quantity: 400 mg - injection, powder for - excipient ingredients: sodium chloride - targocid is indicated for the treatment of the following infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including b-lactam antibiotics: - bone - osteomyelitis; joints - septic arthritis; blood - non-cardiac bacteraemia, septicaemia.

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - acenocoumarol - oral tablet - 1mg